Bristol-Myers Squibb buy Truist Financial Co.
Start price
31.07.26
/
50%
€56.71
Target price
31.07.27
€60.82
Performance (%)
-0.09%
Price
31.07.26
€56.66
Summary
This prediction is currently active. The BUY prediction by Truist_Financial_Co_ for Bristol-Myers Squibb is nearly unchanged. This prediction currently runs until 31.07.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Bristol-Myers Squibb | -0.09% |
| iShares Core DAX® | 3.901% |
| iShares Nasdaq 100 | -2.603% |
| iShares Nikkei 225® | -0.545% |
| iShares S&P 500 | -0.881% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol Myers Squibb (BMY) had its "buy" rating reaffirmed by Truist Financial Corporation. They now have a $70.00 price target on the stock, up from $65.00.
Ratings data for BMY provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€55.56
08.01.25
08.01.25
€63.06
08.01.26
08.01.26
-13.17%
09.01.26
09.01.26
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€53.50
06.10.23
06.10.23
€79.27
06.10.24
06.10.24
-8.08%
07.10.24
07.10.24
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€55.60
15.09.23
15.09.23
€78.67
15.09.24
15.09.24
-20.88%
16.09.24
16.09.24

